z-logo
open-access-imgOpen Access
Trial of Dexamethasone for Chronic Subdural Hematoma
Author(s) -
Peter J. Hutchinson,
Ellie Edlmann,
Diederik Bulters,
Ardalan Zolnourian,
Patrick Holton,
Nigel Suttner,
Kevin Agyemang,
Simon Thomson,
Ian Anderson,
Yahia Al-Tamimi,
Duncan Henderson,
Peter C. Whitfield,
Monica Gherle,
Paul M. Brennan,
Annabel Allison,
Eric Peter Thelin,
Silvia Tarantino,
Beatrice Pantaleo,
Karen Caldwell,
Carol Davis-Wilkie,
Harry Mee,
Elizabeth A. Warburton,
Garry Barton,
Ajai Chari,
Hani J. Marcus,
Andrew T. King,
Antonio Belli,
Phyo Kyaw Myint,
Ian B. Wilkinson,
Thomas Santarius,
Carole Turner,
Simon Bond,
Angelos G. Kolias
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2020473
Subject(s) - chronic subdural hematoma , dexamethasone , medicine , hematoma , surgery
Chronic subdural hematoma is a common neurologic disorder that is especially prevalent among older people. The effect of dexamethasone on outcomes in patients with chronic subdural hematoma has not been well studied.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom